Lexaria Bioscience Corp. (NASDAQ: LEXX)
$2.79
-0.1800 ( -6.06% ) 268.0K
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
Market Data
Open
$2.79
Previous close
$2.97
Volume
268.0K
Market cap
$44.74M
Day range
$2.78 - $3.16
52 week range
$0.73 - $6.85
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Apr 24, 2024 |
10-q | Quarterly Reports | 74 | Apr 09, 2024 |
8-k | 8K-related | 15 | Mar 21, 2024 |
3 | Insider transactions | 1 | Mar 15, 2024 |
8-k | 8K-related | 16 | Mar 15, 2024 |
def | Proxies and info statements | 6 | Mar 06, 2024 |
8-k | 8K-related | 16 | Mar 01, 2024 |
8-k | 8K-related | 28 | Feb 16, 2024 |
8-k | 8K-related | 16 | Jan 30, 2024 |
8-k | 8K-related | 19 | Jan 24, 2024 |